MMAC tumor supressor gene expression in ovarian endometriosis and ovarian adenocarcinoma

European Journal of Gynaecological Oncology

Volumn 28, Issue 4, 2007, Pages 278-281

  Cirpan, T ^a,c   Aygul, S ^a   Terek, M C ^a   Kazandi, M ^a   Dikmen, Y ^a   Zekioglu, O ^b   Sagol, S ^b  

^a Department of Obstetrics and Gynecology ^*

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c EGE UNIVERSITY   (Turkey)

Author keywords

Endometriosis; MMAC protein; Ovarian adenocarcinoma

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; CANCER GRADING; DEMOGRAPHY; ENDOMETRIOSIS; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA;

ADENOCARCINOMA, CLEAR CELL; ADULT; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIOSIS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN DISEASES; OVARIAN NEOPLASMS; PTEN PHOSPHOHYDROLASE;

EID: 34547759284     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lapp T.: "ACOG issues recommendations for the management of endometriosis. American College of Obstetricians and Gynecologists". Am. Fam. Phys., 2000, 62, 1431.
2. Bayramoǧlu H., Duzcan E.: "Atypical epithelial changes and mutant p53 gene expression in ovarian endometriosis". Pathol. Oncol. Res., 2001, 7, 33.
3. Nishida M., Watanabe K., Sato N.: "Malignant transformation of ovarian endometriosis". Gynecol. Obstet. Inv., 2000, 50, 18.
4. Stern R.C., Dash R.: "Malignancy in endometriosis: freqency and comparison of ovarian and extraovarian types". Int. J. Gynecol. Pathol., 2001, 20, 133.
5. Tsugawa K., Jones M.K., Sugimachi K., Sarfeh I.J., Tarnawski A.S.: "Biological role of phosphatase PTEN in cancer and tissue injury healing". Front. Biosci., 2002, 1, 245.
6. Steck P.A., Pershouse M.A., Jasser S.A., Yung W.K., Lin H., Ligon A.H., Langford L.A.: "Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers". Nat. Genet., 1997, 15, 356.
7. Li D.M., Sun H.: "TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta". Cancer Res., 1997, 57, 2124.
8. Di Cristofano A., Pesce B., Cordon-Cardo C., Pandolfi P.P.: "Pten is essential for embryonic development and tumour suppression". Nat. Genet., 1998, 19, 348.
9. Figo Staging of Gynecologic Cancer, International Federation of Gynecology and Obstetrics 1988.
10. American Society for Reproductive Medicine: Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil. Steril., 1997, 67, 817.
11. Sampson J.A.: "Endometrial carcinoma of the ovary arising in endometrial tissue in that organ". Arch. Surg., 1925, 10, 1.
12. Felly K.M., Wells M.: "Precursor lesion of ovarian epithelial malignancy". Histopatology, 2001, 38, 87.
13. Martini M., Ciccarone M., Garganese G.: "Possible involvement of hMLH1, p16 and PTEN in the malignant transformation of endometriosis". Int. J. Cancer, 2002, 102, 398.
14. Sato N., Tsunoda H.: "Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endoemtrioid carcinoma and clear cell carcinoma of the ovary". Cancer Res., 2000, 60, 7052.
15. Obata K., Morland S.J.: "Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors". Cancer Res., 1998, 58, 2095.
16. Yano T, Jimbo H.: "Molecular analysis of clonality in ovarian endometrial cysts". Gynecol. Obstet. Invest., 1999, 47, 41.
17. Tashiro H., Blazes M.S.: "Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies". Cancer Res., 1997, 57, 3935.
18. Risinger J.L., Hayes A.K.: "PTEN/MMAC1 mutations in endometrial cancers". Cancer Res., 1997, 57, 4376.
19. Mutter G.L., Lin M.C.: "Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers". J. Natl. Cancer Inst., 2000, 92, 924.